Polymorphism of clinical manifestation of HPV infection in the genital mucosa - 3-year retrospective study.
CONCLUSIONS: Our study demonstrated that 35% (7/20) of HSIL-confirmed biopsies previously had negative HPV assays. Despite the previous negative HPV tests, a wide variety of HPV genotypes has been detected in most biopsies. In our case, we frequently identified the HPV 59 and 45 strains, 51 cases with HSIL lesions presented a first positive HPV test, 13 cases with low-grade squamous intraepithelial lesion (LSIL) showed three negative HPV tests. Prevention plays an important role in reducing the incidence of cervical cancer cases. The Pap test is now considered the primary prevention method, but consecutive vaccination significantly increases protection against high-risk HPV strains. Education plays an important role in the prophylaxis of HPV infection and cancer. It should be instituted in schools, from puberty age through partnerships or government programs with public health directorates and university hospitals or using European funds. PMID: 32239100 [PubMed - in process]
Publication date: Available online 3 June 2020Source: Life SciencesAuthor(s): Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Vahideh Zarrin, Ebrahim Rahmani Moghadam, Amirhossein Zabolian, Shima Tavakol, Saeed Samarghandian, Masoud Najafi
Publication date: 1 September 2020Source: Life Sciences, Volume 256Author(s): Neda Khalili, Masoud Nouri-Vaskeh, Zahra Hasanpour Segherlou, Amir Baghbanzadeh, Monireh Halimi, Haleh Rezaee, Behzad Baradaran
Publication date: Available online 4 June 2020Source: Colloids and Surfaces B: BiointerfacesAuthor(s): Diksha Gupta, Aishwarya Gangwar, Kiran Jyoti, Vaskuri G.S. Sainaga Jyothi, Rupinder Kaur Sodhi, Neelesh Kumar Mehra, Shashi Bala Singh, Jitender Madan
Publication date: Available online 2 June 2020Source: Colloids and Surfaces B: BiointerfacesAuthor(s): Ping Huang, Guanchun Wang, Zhaohong Wang, Cancan Zhang, Fengmian Wang, Xiaoxiao Cui, Sini Guo, Wei Huang, Rong Zhang, Deyue Yan
Publication date: 24 September 2020Source: Inorganica Chimica Acta, Volume 510Author(s): Thankaraj Salammal Sheena, Rajakumaran Dhivya, Venkatesan Rajiu, K. Jeganathan, Mallayan Palaniandavar, Ganesan Mathan, Mohammad Abdulkader Akbarsha
CONCLUSIONS: The introduction of spacer sequence between chelator and BBN(7-14) led to improved bidistribution. Analogue with tri-Gly spacer is the more promising radiopeptide for targeting GRP receptor than Ser conjugate. Therefore, these analogs can be considered as a candidate for the identification of bombesin-positive tumors. PMID: 32497000 [PubMed - as supplied by publisher]
Conclusions: The findings indicate that gingivitis negatively impacts the adolescents ’ OHRQoL. Moreover, gender, maternal schooling and household income were also associated with OHRQoL.RESUMO: Introdu ção: Qualidade de vida relacionada à saúde bucal (QVRSB) é afetada por diferentes condições clínicas. O objetivo deste estudo foi avaliar o impacto da gengivite na QVRSB de adolescentes. Metodologia: Este estudo de coorte consistiu em uma amostra aleatória de 1.134 escolares iniciado em 2 012, na cidade de Santa Maria, Brasil. Após dois anos, 743 ad...
Conclusion: The Brazilian Portuguese version under study presented a different behavior from the original measurement tool, but proved to be a reliable and valid instrument in assessing the Brazilian population ’ s knowledge about HPV.RESUMO: Objetivo: Verificar a validade interna do construto da vers ão em português de uma ferramenta para aferir o conhecimento da população sobre o papilomavírus humano (HPV). Materiais e métodos: Uma versão brasileira transculturalmente adaptada de uma ferramenta de aferição de conhecimento sobre HPV originalmente projetad...
British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower-income countries.Reuters Health Information
The GAVI vaccines alliance said on Thursday it had raised $8.8 billion from international donor governments, companies and philanthropic foundations to fund its immunisation programmes through to 2025.Reuters Health Information
More News: Bleeding | Cancer | Cancer & Oncology | Cancer of the Uterus | Cancer Vaccines | Cervical Cancer | Education | Endometrial Cancer | Endometriosis | General Medicine | Genital Warts | International Medicine & Public Health | Miscarriage | OBGYN | Ovarian Cancer | Ovaries | Romania Health | Schools | Skin | Skin Biopsy | Study | Universities & Medical Training | Vaccines | WHO | Women